News
Japan’s MHLW approves AstraZeneca’s Imfinzi, Imjudo for liver, lung cancers
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract,...
News
Cellectis, Primera partner for mitochondrial disease gene therapies
Cellectis has entered into a strategic collaboration agreement with Primera Therapeutics to develop a gene editing platform to treat mitochondrial diseases.
Primera Therapeutics is launched...
News
BDR Pharma launches first generic apalutamide to treat prostate cancer in India
BDR Pharmaceutical has launched the first generic apalutamide in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant...
Drug Research
Alligator and Orion expand immuno-oncology research alliance
Alligator Bioscience has expanded its research collaboration and license agreement with Orion Corp., a global pharmaceutical company based in Finland, to discover and develop...
News
Polysciences Announces New Bioprocessing Brand, Kyfora Bio
Polysciences, Inc., a Pennsylvania-based manufacturer of specialty chemicals for research, IVD and medical device applications, plans to create a new brand, Kyfora Bio, representing...
Drug Research
A Brand-New Medication For Dystonia Treatment Is Underway
Thousands of musicians now have hope after substantial progress was made in the search for a dystonia cure by a research team in Korea.
1–3%...
Drug Research
First Time, Treatment For Acute ASPS Given The Go-Ahead
Atezolizumab (Tecentriq), a therapy for advanced alveolar soft tissue sarcoma (ASPS), has received FDA approval for the first time for adults and children two...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read